Advertisement

Topics

Brinton Eaton Company Profile

19:52 EDT 23rd June 2018 | BioPortfolio

Based in Madison, NJ, Brinton Eaton is an elite, boutique advisory firm with a rich history of serving affluent individuals and their families across multiple generations. The firm helps affluent clients protect, grow, administer and ultimately transfer their client's legacy of wealth through a full range of integrated services, including lifetime cash flow projections, financial, tax, estate and retirement planning, investment management, charitable giving and business success planning. Brinton Eaton's clients tend to be corporate executives, professionals, entrepreneurs and retirees with investable assets over $2 million. For more information, visit www.brintoneaton.com.


News Articles [18 Associated News Articles listed on BioPortfolio]

McKesson Co. (MCK) Holdings Increased by Eaton Vance Management

Eaton Vance Management raised its holdings in shares of McKesson Co. by 4.2% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission.

Par Capital Management Has Boosted Its Mckesson (MCK) Holding; Eaton...

Par Capital Management Has Boosted Its Mckesson Holding; Eaton Vance Tax-managed Buy-write Income Fund Has 1.8 Sentiment Eaton Vance Tax-managed Buy-write Income Fund investors sentiment increased to ...

Eaton Vance Management Acquires 879 Shares of McKesson

Eaton Vance Management increased its holdings in McKesson by 2.4% during the first quarter, according to its most recent filing with the Securities and Exchange Commission . The firm owned 37,225 shar...

Catalyst Pharmaceuticals Announces Submission of New Drug Application for Firdapse® for Treatment of Lambert-Eaton Myasthenic Syndrome

CORAL GABLES, Fla., March 29, 2018 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for...

Catalyst Pharmaceuticals Announces FDA Acceptance of NDA and Priority Review Status for Firdapse® (Amifampridine Phosphate) for Lambert-Eaton Myasthenic Syndrome

CORAL GABLES, Fla., May 29, 2018 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therap...

Catalyst seeks FDA nod for Lambert-Eaton myasthenic syndrome therapy

Catalyst Pharmaceuticals filed a new drug application with the FDA seeking approval for Firdapse, or amifampridine, which is  -More- 

Catalyst Pharmaceuticals shares jump after FDA grants priority review status for its lead drug Firdapse

The drug alleviates symptoms of Lambert-Eaton, a rare autoimmune disorder characterized by muscle weakness

Retired Major General Issues Blistering Takedown Of Trump Parade Plan

Gen. Paul Eaton has a scathing response to President Donald Trump’s plans to hold a massive military parade in Washington.

Drugs and Medications [11 Associated Drugs and Medications listed on BioPortfolio]

Guanidinehydrochloridetablets [Key Pharmaceuticals, Inc.]

GUANIDINEHYDROCHLORIDETablets

Erythromycin [Stat Rx USA]

ERYTHROMYCIN ointment

Erythromycin [Rebel Distributors Corp]

Erythromycin Ophthalmic Ointment USP, 0.5% (Sterile)

Erythromycin [Bausch & Lomb Incorporated]

Erythromycin Ophthalmic Ointment USP, 0.5% (Sterile)

Erythromycin [Dispensing Solutions, Inc.]

Erythromycin Ophthalmic Ointment USP, 0.5%

PubMed Articles [8 Associated PubMed Articles listed on BioPortfolio]

Lambert-Eaton myasthenic syndrome: the 60th anniversary of Eaton and Lambert's pioneering article.

This historical review describes the contribution of Drs. Lee M. Eaton and Edward H. Lambert to the diagnosis of myasthenic syndrome on the 60th anniversary of their pioneering article (JAMA 1957) on ...

Coexistence of myasthenia gravis and Lambert-Eaton myasthenic syndrome in a small cell lung cancer patient: A case report.

Myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) are both neuromuscular junction diseases, and some controversy exists whether the 2 diseases occur at the same time.

A Time of Forgetting: Menopause May Hold a Key to Understanding the Development of Alzheimer?s Disease.

One day in the mid-1980s, at New York City's Rockefeller Hospital, two scientists met at opposite poles of their careers. Roberta Diaz Brinton (Figure 1) was a newly minted Ph.D. and a postdoctoral re...

Calcium Channel Autoimmunity: Cerebellar Ataxia and Lambert-Eaton Syndrome Coexisting.

Neuronal calcium channel antibodies are a biomarker of Lambert-Eaton syndrome (LES) and cerebellar ataxia. We have encountered several patients with LES and cerebellar ataxia coexisting and sought to ...

Coexistence of Lambert-Eaton myasthenic syndrome and autoimmune encephalitis with anti-CRMP5/CV2 and anti-GABAB receptor antibodies in small cell lung cancer: A case report.

Autoimmune encephalitis and Lambert-Eaton myasthenic syndrome are classic paraneoplastic neurological conditions common in patients with small cell lung cancer.

Clinical Trials [9 Associated Clinical Trials listed on BioPortfolio]

Use of 3, 4-Diaminopyridine in Lambert Eaton Myasthenic Syndrome

Compassionate use of orphan drug 3,4-Diaminopyridine (DAP) in Treatment of Lambert Eaton Myasthenic Syndrome (LEMS). The purpose of the use of this drug is to decrease the weakness associa...

Randomized Study of 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome

OBJECTIVES: I. Evaluate the safety and effectiveness of 3,4-diaminopyridine (DAP) in the treatment of patients with Lambert-Eaton myasthenic syndrome (LEMS). II. Determine the side-effe...

Treatment of Lambert-Eaton Syndrome With 3,4 Diaminopyridine

The purpose of the study is to provide expanded access (compassionate use) of 3,4 diaminopyridine to patients with Lambert-Eaton myasthenic syndrome (LEMS).

Open Label Trial Of 3,4-Diaminopyridine In Lambert-Eaton Myasthenic Syndrome (LEMS)

The purpose of this study is to determine the effectiveness and adverse effects of 3,4-diaminopyridine for the treatment of the Lambert-Eaton Myasthenic Syndrome (LEMS).

Phase 3 Study to Evaluate Efficacy of Amifampridine Phosphate in Lambert-Eaton Myasthenic Syndrome (LEMS)

This study evaluates the effect of withdrawing amifampridine phosphate treatment from patients with LEMS. One half of the patients will continue to receive amifampridine phosphate and the ...

Companies [9 Associated Companies listed on BioPortfolio]

Brinton Eaton

Based in Madison, NJ, Brinton Eaton is an elite, boutique advisory firm with a rich history of serving affluent individuals and their families across multiple generations. The firm helps affluent clie...

Eaton Corporation

Eaton is a diversified power management company providing energy-efficient solutions that help our customers effectively manage electrical, hydraulic and mechanical power. A globa...

Eaton Vance Mutual Funds

Eaton Vance is one of the oldest financial services firms in the United States, with a history dating to 1924. Reflecting the traditional values of its home in Boston, Massachusetts, Eaton Vance estab...

Eaton Vance Corp.

Eaton's Cooper Lighting business

More Information about "Brinton Eaton" on BioPortfolio

We have published hundreds of Brinton Eaton news stories on BioPortfolio along with dozens of Brinton Eaton Clinical Trials and PubMed Articles about Brinton Eaton for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Brinton Eaton Companies in our database. You can also find out about relevant Brinton Eaton Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record